CSIMarket
 
Mainz Biomed N v   (NASDAQ: MYNZ)
Other Ticker:  
 
 

Mainz Biomed N V Growth Comparisons

Select each growth Category to receive further Information



MYNZ Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 69 % -4.85 % 1.04 % 1.01 %
Q / Q Revenue Growth (Q4 MRQ) - 1.47 % 3.25 % 1.25 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 69 % -12.18 % -3.72 % %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - -8.23 % -0.48 % 0.33 %
Revenue 5 Year Average Growth - 8.81 % 8.02 % 7.61 %


MYNZ's Growth Comparisons in IV. Quarter 2023




Facing 69% year on year sales decrease in the forth quarter 2023, to $ 1 millions, Mainz Biomed N V reported smaller declines than the Major Pharmaceutical Preparations industry with -4.85%, and less than 1.04% growth in the Healthcare sector. Although Major Pharmaceutical Preparations industry's Sales gains were softer then 1.01% overall market growth, Mainz Biomed N V and the Healthcare sector have delivered above average market Sales growth.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the forth quarter 2023 earnings reports, average yearly sales growth is 7.61%.


Growth Rates of MYNZ's Income in the forth quarter 2023


MYNZ Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - -81.29 % -52.32 % 2.07 %
Seq. Operating Income Change (Q4 MRQ) - -61.46 % -9.57 % -4.56 %
Y / Y Operating Income Growth (Q4 TTM) - -43.87 % -35.45 % -4.39 %
Seq. Operating Income Growth (Q4 TTM) - -23.82 % -15.13 % -0.45 %
Operating Income 5 Year Avg. Change - 3.06 % 6.12 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - -37.5 % -21.14 % 6.64 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - 20.91 % 147.34 % -13.22 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -41.88 % -38.29 % -1.2 %
Seq. Income from Cont. Ops. Change (Q4 TTM) - 1.93 % 7.74 % 1.92 %
Income from Cont. Ops. 5 Year Avg. Change - -3.67 % -9.76 % 7.3 %

MYNZ Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - -36.93 % -21.8 % 2.62 %
Q / Q Net Income Growth (Q4 MRQ) - -65.19 % -40.36 % -19.44 %
Y / Y Net Income Change (Q4 TTM) - -19.61 % -15.92 % -0.12 %
Seq. Net Income Change (Q4 TTM) - 1.52 % 5.41 % 0.97 %
Net Income 5 Year Avg. Growth - 4.41 % -3.41 % 7.44 %

MYNZ's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - -26.68 % -21.14 % 6.64 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - 58.17 % 147.34 % -13.22 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - - - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.66 % -9.76 % 7.3 %



MYNZ EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - -26.02 % -21.8 % 7.3 %
Q / Q EPS Net Growth (Q4 MRQ) - -54.46 % -40.36 % -19.44 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 38435.43 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) - - - 0.03 %
EPS Net 5 Year Avg. Change - 4.41 % -3.41 % 7.44 %



Mainz Biomed N V reported bottom-line of $ -64.80 in the forth quarter, compare to $ -74.40 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -26.02%, while Healthcare sector decreased by -21.8%, and overall market improved by 2.62%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the forth quarter 2023 financial results, average yearly income per share growth is 7.44%.

MYNZ Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -17.91 % -8.71 % -5.17 %
Seq. Free Cash Flow Change (Q4 MRQ) - -22.06 % -5.42 % -4.84 %
Y / Y Free Cash Flow Change (Q4 TTM) - -16.46 % -10.69 % 4.98 %
Seq. Free Cash Flow Change (Q4 TTM) - -5.25 % -2.81 % 5.63 %
Free Cash Flow 5 Year Avg. Change - 11.97 % 7 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) 96.41 % 116.84 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - 189.25 % - -
Y / Y Net Cash Flow Change (Q4 TTM) 96.41 % - - -
Seq. Net Cash Flow Change (Q4 TTM) - 111.12 % -52.33 % 526.11 %
Net Cash Flow 5 Year Avg. Change - 1.43 % 11.22 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 82.06 % 12.47 % 2.21 % -10.32 %
Seq. Capital Expenditures Change (Q4 MRQ) - 25.88 % 15.64 % -0.96 %
Y / Y Capital Expenditures Change (Q4 TTM) 82.06 % 7.52 % 6.52 % 30.84 %
Seq. Capital Expenditures Change (Q4 TTM) 82.06 % 3.26 % 1.53 % 35.86 %
Capital Expenditures 5 Year Avg. Change - 13.67 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com